Sublethal vancomycin-induced ROS mediating antibiotic resistance in Staphylococcus aureus

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Resistance

Background:

• Staphylococcus aureus is a major cause of human infections and exhibits rapid antibiotic resistance.
• Mechanisms of antibiotic resistance in S. aureus are not fully understood.
• Oxidative stress is increasingly recognized as a factor in antibiotic efficacy.

Purpose of the Study:

• To investigate the role of reactive oxygen species (ROS) in vancomycin resistance in Staphylococcus aureus.
• To explore the relationship between sublethal vancomycin treatment, ROS production, and antibiotic resistance.
• To identify potential therapeutic targets for combating vancomycin-resistant S. aureus.

Main Methods:

• Treatment of heterogeneous vancomycin-resistant S. aureus (hVRSA) with sublethal vancomycin.
• Measurement of reactive oxygen species (ROS) levels in bacterial strains.
• Assessment of vancomycin susceptibility in hVRSA and vancomycin-susceptible S. aureus (VSSA) strains under varying ROS conditions.

Main Results:

• Sublethal vancomycin treatment induced protective ROS production in hVRSA.
• Reducing ROS levels in hVRSA strains increased their susceptibility to vancomycin.
• Low doses of ROS appeared to promote the survival of VSSA strains under vancomycin exposure.
• Modest ROS generation was found to be protective for vancomycin resistance in hVRSA.

Conclusions:

• Reactive oxygen species play a dual role in vancomycin resistance of Staphylococcus aureus.
• Modest ROS generation may contribute to vancomycin resistance in hVRSA.
• Targeting ROS pathways could offer novel therapeutic strategies against hVRSA infections.